~~<i id='7FB3D8845F'><strike id='7FB3D8845F'><tt id='7FB3D8845F'><pre id='7FB3D8845F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

focus

author：leisure time 2025-10-01 21:41:03 - browse：7

JOHNSON & JOHNSON HEADQUARTERS — Daniel Hulshizer/AP

Eight months into his tenure, Johnson & Johnson’s R&D chief is putting a big emphasis on medicines for cancer, treatment-resistant depression, and autoimmune disease.

To sharpen that focus, R&D chief John Reed told STAT that the company is de-emphasizing two areas that have been mainstays for the drug and medical device giant: infectious disease and vaccines, as well as medicines targeting kidney disease and rare eye conditions.

The disclosures were made in an interview ahead of an investor meeting Reed is leading Tuesday aimed at generating excitement about the company’s research and development efforts.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Cosmetics set for new safety regulation. Why the industry is on board

focus

hotspot

focus

leisure time

explore

AdobeMosteverythingislookingupforOrexo,thecompanyreportedonitssecondquarterearningscallonTuesday.Tha

WSS

A public scorecard can help hold safety

Key House panel plots a new health care package

Medicare has a new plan to address drug shortages

Custom gene therapy hints at new path for rare disease treatments

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Digital health: a case of mistaken identity

hotspot

focus

focus

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Citing H5N1 threat, CDC urges peak flu monitoring this summer

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

BioMarin wins approval for gene therapy to treat hemophilia A

Addressing health care workers' trauma can help fight burnout

Apple is now the first public company to be valued at $3 trillion

Medicare to cover more brain scans for Alzheimer’s patients

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

A public scorecard can help hold safety

hotspot

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

H5N1 bird flu outbreak: Second human case reported, in Michigan

Digital health: a case of mistaken identity

WHO calls for emergency meeting on new China virus, as cases spread

Startup Neumora takes a novel depression drug to Phase 3

As a primary care physician, here's how I hope to partner with AI

focus

focus

leisure time

explore